Press Releases All News 2019 2018 2017 2016 2015 2014 Relmada Therapeutics to Present at LD Micro "Main Event" Investor Conference November 29, 2016 Relmada Therapeutics to Present at the Sidoti & Company Fall 2016 Emerging Growth Convention October 27, 2016 Relmada Therapeutics Announces Issuance of Key U.S. Patent Covering d-Methadone, an NMDA Receptor Antagonist, for the Treatment of Depression and Other Psychiatric Symptoms October 19, 2016 Relmada Therapeutics to Present at the 15th Annual BIO Investor Forum October 6, 2016 Relmada Therapeutics' Chief Scientific Officer Dr. Richard Mangano to Speak about d-Methadone as a Potential Rapid Acting Antidepressant at Neuro Advance Boston September 28, 2016 Relmada Therapeutics to Present at the Ladenburg Thalmann 2016 Healthcare Conference September 22, 2016 Relmada Therapeutics to Present at the 2016 Aegis Growth Conference September 20, 2016 Relmada Therapeutics Files Amended Complaint Against Laidlaw and Its Principals, Matthew Eitner and James Ahern September 14, 2016 Pharmaceutical Industry Leader Ronald M. Burch Joins Relmada Therapeutics Advisory Team September 12, 2016 Relmada Therapeutics to Present at the Rodman & Renshaw 18th Annual Global Investment Conference September 7, 2016 1 2 3 Next »
Relmada Therapeutics to Present at the Sidoti & Company Fall 2016 Emerging Growth Convention October 27, 2016
Relmada Therapeutics Announces Issuance of Key U.S. Patent Covering d-Methadone, an NMDA Receptor Antagonist, for the Treatment of Depression and Other Psychiatric Symptoms October 19, 2016
Relmada Therapeutics' Chief Scientific Officer Dr. Richard Mangano to Speak about d-Methadone as a Potential Rapid Acting Antidepressant at Neuro Advance Boston September 28, 2016
Relmada Therapeutics to Present at the Ladenburg Thalmann 2016 Healthcare Conference September 22, 2016
Relmada Therapeutics Files Amended Complaint Against Laidlaw and Its Principals, Matthew Eitner and James Ahern September 14, 2016
Pharmaceutical Industry Leader Ronald M. Burch Joins Relmada Therapeutics Advisory Team September 12, 2016
Relmada Therapeutics to Present at the Rodman & Renshaw 18th Annual Global Investment Conference September 7, 2016